More GRAS DHA for Martek
This article was originally published in The Tan Sheet
Executive Summary
FDA affirms an alternative form of alga-derived docosahexaenoic acid for food applications, (different from the alga used in fortified infant formulas) as generally recognized as safe, Martek Biosciences announces March 3. Martek currently is in talks with food manufacturers to include the oil in cheese, yogurt and nutrition bars, and is hopeful their first DHA-containing food product will be out in 2004. The Columbia, Md.-based firm acquired the technology to make food-specific DHA via its 2003 purchase of OmegaTech (1"The Tan Sheet" April 1, 2003, p. 3)...
You may also be interested in...
Martek Expands Access To DHA Food, Beverage Market With OmegaTech Buy
Martek Biosciences is looking to gain greater access to the nascent DHA-fortified food and beverage market with the acquisition of Boulder, Colo.-based OmegaTech
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.